Webinar Announcement: Antibody Identification – Session 3/3
In this final session of the ABID webinar series, we’ll explore some of the more unusual and challenging aspects of antibody identification
MM250804: Multiple myeloma
This week’s case explored a blood film from a patient with known multiple myeloma, now presenting with progressive symptoms and worsening cytopenias.
![ABID – Putting it into practice webinar [2/3]](https://onlycells.co.uk/wp-content/uploads/ABID2_thumbnail-1-768x432.jpg)
ABID – Putting it into practice webinar [2/3]
Following on from the foundations laid in Session 1: Tools of the Trade, this session focused on applying key antibody identification techniques through real-world case discussions.
Morphology Monday | Case MM250804
This week’s case comes from a 69 year old male presenting with a increasing fatigue and back back over the past several months. He has also experiences recurrent infections recently.
MM250728: Sickle cell disease
This week’s Morphology Monday case features a patient with known Sickle Cell Disease (SCD)
Webinar Announcement: Antibody Identification – Session 2/3
Registration is now open for Session 2 of the Antibody Identification (ABID) Webinar Series: Putting it into practice
Morphology Monday | Case MM250728
This week’s Morphology Monday case comes from a 26-year-old individual with a known history of anaemia who presented to A&E with generalised fatigue, mild jaundice, and bone pain in the lower limbs.
MM250721: Acute lymphoblastic leukaemia (ALL)
The findings are highly suggestive of an acute leukaemia, and given the age of the patient it raises a strong suspicion for acute lymphoblastic leukaemia (ALL)
Morphology Monday | Case MM250721
This week’s case features a 14-year-old male who had just celebrated his birthday when he presented to hospital with an abnormal full blood count and some concerning symptoms.
MM250714: Thalassaemia
These findings raised the possibility of a haemoglobinopathy. Given the red cell morphology and raised RDW, follow-up testing was advised.